tirzepatide and thyroid cancer GLP-1RA cancer: New study suggests detection bias, not causation Thyroid cancer and GLP-1RA therapy
Description
Surprisingly, despite the reduction in plasma DPP-4 activity, sitagliptin did not lower plasma TG excursions or apoB48 nor apoB100 levels during a LTT, with or without tyloxapol (Figure 9)
Cramon, L
Journal of Clinical and Aesthetic Dermatology
In fact, we have an incredibly strong understanding of their safety profile
Efficacy and safety of tirzepatide in overweight and obese subjects
We will provide guidance, answer any questions, and help you assess whether Ozempic is the right option to achieve your health and weight management goals
